HER2-targeted CAR T-cell Therapy Safe, With Promising Antitumor Activity in Patients With Advanced Sarcoma
ATLANTA – A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2...
ATLANTA – A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2...
ATLANTA – A combination of the anti-CTLA-4 immunotherapeutic ipilimumab (Yervoy) and the anti-PD-1 immunotherapeutic nivolumab (Opdivo) showed clinical benefit...
ATLANTA – Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients...
Single test could identify one prognostic and seven predictive biomarkers in blood PHILADELPHIA – Guardant360, a liquid biopsy test...
Clinical trial data may not be generalizable to real-world population PHILADELPHIA – Patients with advanced prostate cancer who had...
PHILADELPHIA – Among melanoma patients treated with anti-PD-1 immunotherapy, consumption of a high-fiber diet was associated with higher gut...
PHILADELPHIA – Many patients diagnosed with colorectal cancer before age 50 were initially misdiagnosed, which may lead to diagnosis...
The American Association for Cancer Research (AACR) will be hosting its 110th Annual Meeting, March 29-April 3, 2019, at...
SAN ANTONIO – Survivors of early-stage breast cancer who participated in a lifestyle intervention on healthy habits lost weight...
SAN ANTONIO – Treatment with oxybutynin helped reduce the frequency and intensity of hot flashes for women who could...